Thursday, 19 June 2025
Aleph Farms, the cultivated meat company growing steaks directly from non-genetically modified animal cells, has announced the completion of a $105 million Series B funding round. The funding round was led by the Growth Fund of L Catterton, the largest global consumer-focused private equity firm, and DisruptAD, one of the largest venture platforms in the Middle East. It also saw participation from Skyviews Life Science, as well as a consortium of leading global food and meat companies including Thai Union, BRF, and CJ CheilJedang. Additionally, existing investors, including VisVires New Protein, Strauss Group, Cargill, Peregrine Ventures, and CPT Capital, participated in the Series B funding round. To date, the company has raised more than $118 million.
The company will use this latest round of investment to execute its plans for large scale global commercialisation and portfolio expansion into new types of animal protein. Its near-term milestones include scaling-up manufacturing, growing operations internationally, and expanding the product lines and technology platform ahead of an initial market launch in 2022.
Aleph Farms is the first company to grow steaks directly from the cells of cows, and have revealed not only the world’s first cell-cultured thin-cut steak in 2018, but also the world’s first cell-cultured ribeye earlier this year.
The company’s mission is to create more resilient, equitable and sustainable global food systems through a collaborative global platform for local cultivated meat production independent of the availability of local natural resources such as arable land, water, and under any climate.
